ANTXR1 and glioblastoma: We analyzed eleven different types of cancer for differences of stromal score when there is high or low expression of ANTXR1 in tumors (basal breast cancer, melanoma, lung squamous cancer, lung adenocarcinoma, colorectal adenocarcinoma, head and neck squamous cell carcinoma, cervical squamous cell carcinoma, bladder urothelial carcinoma, kidney renal clear cell carcinoma, glioblastoma, and metastatic melanoma).